Proliferation of Bifidobacteria by Oligosaccharides and Their Useful Effect on Human Health
Open accessThe DOI matches its Crossref record.
Abstract
Studies of oligosaccharides have recently become common, especially in Japan. This has been because of findings of marked biofunctions and usefulness of fructooligosaccharides (FOS) for human health due to their effect of improving the intestinal microflora. In this paper, we demonstrate several useful characteristics of FOS such as cholesterol reduction, suppression of putrefaction, normalization of microbial disorders of the colon and alleviation of constipation in clinical studies. It seems that the usefulness of FOS is related to the proliferation of bifidobacteria and other saccharolytic intestinal bacteria and also short chain fatty acids produced by these organisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Prebiotics: The Concept Revisited1,
Roberfroid, M. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.3.830s · Cited by 1,498
Brouns, F., Bjorck, I., Frayn, K. N., Gibbs, A. L., Lang, V., Slama, G., & Wolever, T. M. S. (2005) · Nutrition Research Reviews · doi:10.1079/nrr2005100 · Cited by 1,093
Xu, Z., Hu, C., Xia, M., Zhan, X., & Wang, M. (2003) · Poultry Science · doi:10.1093/ps/82.6.1030 · Cited by 885
Inulin-Type Fructans: Functional Food Ingredients
Roberfroid, M. B. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.11.2493s · Cited by 878
Introducing inulin-type fructans
Roberfroid, M. B. (2005) · British Journal of Nutrition · doi:10.1079/bjn20041350 · Cited by 793
Campbell, J. M., Fahey, G. C., & Wolf, B. W. (1997) · The Journal of Nutrition · doi:10.1093/jn/127.1.130 · Cited by 719
Applications of inulin and oligofructose in health and nutrition
Kaur, N., & Gupta, A. K. (2002) · Journal of Biosciences · doi:10.1007/bf02708379 · Cited by 673
Kleessen, B., Sykura, B., Zunft, H., & Blaut, M. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1397 · Cited by 585
Costabile, A., Klinder, A., Fava, F., Napolitano, A., Fogliano, V., Leonard, C., Gibson, G. R., & Tuohy, K. M. (2008) · British Journal of Nutrition · doi:10.1017/s0007114507793923 · Cited by 444
Prebiotics: why definitions matter
Hutkins, R. W., Krumbeck, J. A., Bindels, L. B., Cani, P. D., Fahey, G., Goh, Y. J., Hamaker, B., Martens, E. C., Mills, D. A., Rastal, R. A., et al. (2016) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2015.09.001 · Cited by 437
Roberfroid, M. B., & Delzenne, N. M. (1998) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.18.1.117 · Cited by 344
Effects of inulin on faecal bifidobacteria in human subjects
Kruse, H.-P., Kleessen, B., & Blaut, M. (1999) · British Journal of Nutrition · doi:10.1017/s0007114599001622 · Cited by 307
Hsu, C.-K., Liao, J.-W., Chung, Y.-C., Hsieh, C.-P., & Chan, Y.-C. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.6.1523 · Cited by 278
Therapeutical use of probiotic formulations in clinical practice
Iannitti, T., & Palmieri, B. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2010.05.004 · Cited by 260
Prebiotics and lipid metabolism
Delzenne, N. M., & Williams, C. M. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200202000-00009 · Cited by 220
The effect of ingestion of inulin on blood lipids and gastrointestinal symptoms in healthy females
Pedersen, A., Sandström, B., & Van Amelsvoort, J. M. M. (1997) · British Journal of Nutrition · doi:10.1079/bjn19970141 · Cited by 206
Fructans: Prebiotics and immunomodulators
Peshev, D., & Van den Ende, W. (2014) · Journal of Functional Foods · doi:10.1016/j.jff.2014.04.005 · Cited by 175
Bornet, F. R. J., Brouns, F., Tashiro, Y., & Duvillier, V. (2002) · Digestive and Liver Disease · doi:10.1016/s1590-8658(02)80177-3 · Cited by 168
Self-citationInulin and oligofructose: effects on lipid metabolism from human studies
Williams, C. M., & Jackson, K. G. (2002) · British Journal of Nutrition · doi:10.1079/bjn/2002546 · Cited by 77
“Similar reductions in blood cholesterol were reported to have been observed in a group of Japanese subjects with hyperlipidemia (Hidaka et al. 1991).”
Result
Metadata
- Authors
- HIDAKA, H., TASHIRO, Y., & EIDA, T.
- Venue
- Bifidobacteria and Microflora
- Publisher
- BMFH Press
- Published
- 1991
- Volume
- 10
- Issue
- 1
- Pages
- 65-79
- ISSN
- 0286-9306 (ISSN-L)
- 1884-5126
- OpenAlex
- W1968178401
- Cited by
- 157
- References
- 0
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.